{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:22:11Z","timestamp":1779920531368,"version":"3.53.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbr.2024.115252","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:52:45Z","timestamp":1726210365000},"page":"115252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Central cholinergic transmission modulates endocannabinoid-induced marble-burying behavior in mice"],"prefix":"10.1016","volume":"476","author":[{"given":"Chhatrapal","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant Sudhir","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2024.115252_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1176\/foc.5.3.foc299","article-title":"Obsessive-compulsive disorder: an update for the clinician","volume":"3","author":"Koran","year":"2007","journal-title":"Focus Madison"},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neubiorev.2010.02.004","article-title":"The neurobiology of repetitive behavior: Of mice","volume":"35","author":"Langen","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.bbr.2024.115252_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","article-title":"The effects of cannabinoids on the brain","volume":"58","author":"Ameri","year":"1999","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2011.04.031","article-title":"Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice","volume":"223","author":"Umathe","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2010.11.027","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"35","author":"Gomes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette\u2019s syndrome with \u03949-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"Muller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2024.115252_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0272-7358(98)00059-2","article-title":"Tourette\u2019s and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?","volume":"19","author":"Sheppard","year":"1999","journal-title":"Clin. Psychol. Rev."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2024.115252_bib9","first-page":"221","article-title":"Endocannabinoids in the central nervous system - an overview, Prostaglandins Leukot. Essent. Fat. Acids","volume":"66","author":"Fride","year":"2002"},{"issue":"5","key":"10.1016\/j.bbr.2024.115252_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"C. Kenner, Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2024.115252_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2007.09.022","article-title":"The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons","volume":"578","author":"Lau","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn. Schmiede Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2024.115252_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.bbr.2024.115252_bib15","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.neuropharm.2011.12.030","article-title":"Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor","volume":"62","author":"Umathe","year":"2012","journal-title":"Neuropharmacology"},{"issue":"6743","key":"10.1016\/j.bbr.2024.115252_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbr.2024.115252_bib17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-\u03b1 agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu","year":"2005","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2008.08.005","article-title":"The Lipid Messenger OEA Links Dietary Fat Intake to Satiety","volume":"8","author":"Schwartz","year":"2008","journal-title":"Cell Metab."},{"issue":"17","key":"10.1016\/j.bbr.2024.115252_bib19","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1097\/00001756-199511270-00033","article-title":"Epibatidine and ABT 418 reveal selective losses of \u03b14\u03b22 nicotinic receptors in alzheimer brains","volume":"6","author":"Warpman","year":"1995","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.bbr.2024.115252_bib20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1176\/appi.ajp.158.7.1058","article-title":"Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain","volume":"158","author":"Perry","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbr.2024.115252_bib21","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bcp.2007.06.015","article-title":"Nicotinic receptors as CNS targets for Parkinson\u2019s disease","volume":"74","author":"Quik","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pscychresns.2007.04.002","article-title":"Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders","volume":"156","author":"Mohamed","year":"2007","journal-title":", Psychiatry Res.\u00a0Neuroimaging"},{"issue":"12","key":"10.1016\/j.bbr.2024.115252_bib23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-3223(03)00474-8","article-title":"Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study","volume":"54","author":"Smith","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0010-440X(99)90126-8","article-title":"Low prevalence of smoking among patients with obsessive-compulsive disorder","volume":"40","author":"Bejerot","year":"1999","journal-title":"Compr. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-3223(01)01207-0","article-title":"Effect of nicotine on quinpirole-induced checking behavior in rats: Implications for obsessive-compulsive disorder","volume":"51","author":"Tizabi","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2024.115252_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148713","article-title":"Central cholinergic transmission affects the compulsive-like behavior of mice in marble-burying test","volume":"1825","author":"Patel","year":"2024","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2024.115252_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/JMN:13:1-2:55","article-title":"Anandamides inhibit binding to the muscarinic acetylcholine receptor","volume":"13","author":"Lagalwar","year":"1999","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(01)02825-6","article-title":"Interaction of anandamide with the M1 and M4 muscarinic acetylcholine receptors","volume":"915","author":"Christopoulos","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2024.115252_bib29","first-page":"1","article-title":"Cannabinoid modulation of emotion, memory, and motivation","author":"Campolongo","year":"2015","journal-title":"Cannabinoid Modul. Emot.\u00a0Mem.\u00a0Motiv."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1369-1600.2011.00314.x","article-title":"Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking","volume":"17","author":"Gamaleddin","year":"2012","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Njung\u2019e","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.bbr.2024.115252_bib32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2009.06.020","article-title":"Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors","volume":"33","author":"Umathe","year":"2009","journal-title":"Prog. Neuro\u00a0Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2024.115252_bib33","first-page":"1","article-title":"Behavioral phenotyping for autism spectrum disorders in mice","author":"Chang","year":"2017","journal-title":"Curr. Protoc. Toxicol."},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145701002632","article-title":"Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Bagdy","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0269881111431749","article-title":"Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of exposure to stress and modulation by mecamylamine","volume":"26","author":"Bhutada","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02977717","article-title":"M. Metna-Laurent, Antinociceptive effect of nicotine in various pain models in the mouse","volume":"28","author":"Han","year":"2005","journal-title":"Arch. Pharm. Res."},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1476-5381.1975.tb06938.x","article-title":"Behavioural changes induced in conscious mice by intracerebroventricular injection of catecholamines, acetylcholine and 5-hydroxytryptamine","volume":"55","author":"Herman","year":"1975","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib38","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00170.2009","article-title":"Central acetylcholinesterase inhibition improves hemodynamic counterregulation to severe blood loss in alcohol-intoxicated rats","volume":"297","author":"Mathis","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0253-7613.55205","article-title":"Role of central muscarinic cholinergic receptors in the formalin-induced pain in rats","volume":"41","author":"Tamaddonfard","year":"2009","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.bbr.2024.115252_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112997","article-title":"Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice","volume":"399","author":"Patel","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2024.115252_bib41","unstructured":"K.B.J. Paxinos, G., Franklin, The Mouse Brain in Stereotaxic Coordinates, Acad. Press. (2001)."},{"key":"10.1016\/j.bbr.2024.115252_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pbb.2015.10.004","article-title":"Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol","volume":"139","author":"Jain","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2486\/indhealth.23.75","article-title":"Cholinesterase activities in the blood and brain of rats and mice, as determined by a rapid colorimetric method","volume":"23","author":"Tomokuni","year":"1985","journal-title":"Ind. Health"},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2024.115252_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","article-title":"Endocannabinoid-mediated retrograde modulation of synaptic transmission","volume":"29","author":"Ohno-Shosaku","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2024.115252_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-2999(97)00082-4","article-title":"Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices","volume":"324","author":"Gifford","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbr.2024.115252_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"V. Di Marzo, Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuron.2015.08.035","article-title":"Habenular CB1 receptors control the expression of aversive memories","volume":"88","author":"Soria-Gomez","year":"2015","journal-title":"Neuron"},{"issue":"No. 126","key":"10.1016\/j.bbr.2024.115252_bib51","first-page":"226","article-title":"Use of a nicotine receptor agonist in the treatment of obsessive compulsive behavior","volume":"511","author":"Carlsson","year":"2000","journal-title":"Eur. no. Pat."},{"key":"10.1016\/j.bbr.2024.115252_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2014.00017","article-title":"Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf\/j mice","volume":"6","author":"Amodeo","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.56808\/3027-7922.2390","article-title":"Evaluating the effect of donepezil on depression and obsessive\u2013compulsion disorder in mice models and proposing the mechanism involved","volume":"42","author":"Mesripour","year":"2018","journal-title":"Thai J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002130050048","article-title":"The role of nicotinic and muscarinic acetylcholine receptors in attention","volume":"148","author":"Mirza","year":"2000","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.bbr.2024.115252_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-013-3323-2","article-title":"The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder","volume":"230","author":"Yankelevitch Yahav","year":"2013","journal-title":"Psychopharmacol. Berl."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ijnp\/pyab079","article-title":"Effects of the partial M1 muscarinic cholinergic receptor agonist CDD-0102A on stereotyped motor behaviors and reversal learning in the BTBR mouse model of autism","volume":"25","author":"Athnaiel","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.bbr.2024.115252_bib57","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","article-title":"Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats","volume":"33","author":"Boulougouris","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2024.115252_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2003.09.020","article-title":"Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: Differential effects on selectivity, impulsivity and compulsivity","author":"Chudasama","year":"2003","journal-title":"Behav. Brain Res. 146 (1\u20132)"},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cercor\/bhj120","article-title":"Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific","volume":"17","author":"Clarke","year":"2007","journal-title":"Cereb. Cortex."},{"key":"10.1016\/j.bbr.2024.115252_bib60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000524086","article-title":"Inhibitory effects of cannabinoids on acetylcholinesterase and Butyrylcholinesterase enzyme activities","author":"Puopolo","year":"2022","journal-title":"Med. Cannabis Cannabinoids."},{"issue":"5","key":"10.1016\/j.bbr.2024.115252_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050758","article-title":"Cannabis constituents and acetylcholinesterase interaction: molecular docking, in vitro studies and association with CNR1 RS806368 and ACHE RS17228602","volume":"10","author":"Furqan","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.bbr.2024.115252_bib62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0091-3057(78)90280-0","article-title":"Tetrahydrocannabinol and acetylcholinesterase","volume":"8","author":"Moss","year":"1978","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.bbr.2024.115252_bib63","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/mp060066m","article-title":"A molecular link between the active component of marijuana and Alzheimer\u2019s disease pathology","volume":"3","author":"Eubanks","year":"2006","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.bbr.2024.115252_bib64","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.apjtm.2016.09.009","article-title":"Acetylcholinesterase, butyrylcholinesterase and paraoxonase 1 activities in rats treated with cannabis, tramadol or both","volume":"9","author":"Abdel-Salam","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.61.1.70","article-title":"Quality of life in patients with Parkinson\u2019s disease: development of a questionnaire","volume":"61","author":"De Boer","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2024.115252_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1755-5949.2011.00249.x","article-title":"Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets","volume":"18","author":"Scarr","year":"2012","journal-title":", CNS Neurosci."},{"key":"10.1016\/j.bbr.2024.115252_bib67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-neuro-062012-170433","article-title":"Muscarinic signaling in the brain","volume":"36","author":"Thiele","year":"2013","journal-title":"Annu. Rev. Neurosci."},{"issue":"15","key":"10.1016\/j.bbr.2024.115252_bib68","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/j.1742-4658.2007.05935.x","article-title":"Muscle and neuronal nicotinic acetylcholine receptors","volume":"274","author":"Kalamida","year":"2007","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"23","key":"10.1016\/j.bbr.2024.115252_bib70","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1523\/JNEUROSCI.22-23-10182.2002","article-title":"Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus","volume":"22","author":"Kim","year":"2002","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0704220","article-title":"Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors","volume":"134","author":"Mang","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(99)00609-3","article-title":"Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)","volume":"383","author":"Gifford","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib73","first-page":"90","article-title":"Aberrations in nicotinic acetylcholine receptor structure, function, and expression: Implications in disease","volume":"5","author":"Salamone","year":"2000","journal-title":"McGill J. Med."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-020-00309-z","article-title":"Efficacy of nicotine administration on obsessions and compulsions in OCD: A systematic review","volume":"19","author":"Piacentino","year":"2020","journal-title":"Ann. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of \u03c3 receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib76","first-page":"217","article-title":"The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA","volume":"57","author":"Skuza","year":"2006","journal-title":"Recept. Antagon. Force Swim Test. Rats.\u00a0J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0091-3057(98)00093-8","article-title":"Beneficial effects of acute and repeated administrations of \u03c3 receptor agonists on behavioral despair in mice exposed to tail suspension","volume":"61","author":"Ukai","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib78","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/npp.2012.210","article-title":"The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area","volume":"38","author":"Buczynski","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.bbr.2024.115252_bib79","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00213-015-4196-3","article-title":"Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives","volume":"233","author":"Scherma","year":"2016","journal-title":"Psychopharmacol. Berl."},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib80","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1124\/jpet.106.116830","article-title":"Nicotinic facilitation of \u03949-tetrahydrocannabinol discrimination involves endogenous anandamide","volume":"321","author":"Solinas","year":"2007","journal-title":"J. Pharmacol. Exp."},{"key":"10.1016\/j.bbr.2024.115252_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuropharm.2013.03.038","article-title":"\u03b14\u03b22 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats","volume":"71","author":"Quik","year":"2013","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.bbr.2024.115252_bib82","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaac.2011.06.011","article-title":"Developmental alterations of frontal-striatal-thalamic connectivity in obsessive-compulsive disorder","volume":"50","author":"Fitzgerald","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbr.2024.115252_bib83","first-page":"477","article-title":"The neurobiology of obsessive-compulsive disorder: new findings from functional magnetic resonance imaging (I)","volume":"50","author":"Pena-Garijo","year":"2010","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib84","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/mol.108.052274","article-title":"Acetylcholine-stimulated [3H] GABA release from mouse brain synaptosomes is modulated by \u03b14\u03b22 and \u03b14\u03b15\u03b22 nicotinic receptor subtypes","volume":"75","author":"McClure-Begley","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/jpet.112.194084","article-title":"Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens","volume":"342","author":"Perez","year":"2012","journal-title":"J. Pharmacol. Exp."},{"issue":"7","key":"10.1016\/j.bbr.2024.115252_bib86","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bcp.2009.06.024","article-title":"Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity \u03b14\u03b22 subunit combination","volume":"78","author":"Anderson","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbr.2024.115252_bib87","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.02.013","article-title":"Association analysis of sigmar1 with major depressive disorder and SSRI response","volume":"58","author":"Kishi","year":"2010","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib88","first-page":"917","article-title":"Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with \u03b14\u03b22 neuronal nicotinic acetylcholine receptor orthosteric ligands","volume":"334","author":"Weltzin","year":"2010","journal-title":"J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib89","first-page":"184","article-title":"Desformylflustrabromine Modulates \u03b14\u03b22 neuronal nicotinic acetylcholine receptor high- and low-sensitivity isoforms at allosteric clefts containing the b2 Subunit","volume":"354","author":"Weltzin","year":"2015","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.bbr.2024.115252_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00115","article-title":"Acetylcholine release in mouse hippocampal CA1 preferentially activates inhibitory-selective interneurons via \u03b14\u03b22* nicotinic receptor activation","volume":"9","author":"Bell","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"60","key":"10.1016\/j.bbr.2024.115252_bib91","article-title":"Some effects of scopolamine, atropine, and amphetamine in three behavioral situations","volume":"3","author":"Carlton","year":"1961","journal-title":"Pharmacologist"},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/h0045063","article-title":"Cholinergic mechanisms in the control of behavior by the brain","volume":"70","author":"Carlton","year":"1963","journal-title":"Psychol. Rev."},{"issue":"126 (","key":"10.1016\/j.bbr.2024.115252_bib93","article-title":"Effects of scopolamine on discriminated responding in the rat","author":"Hearst","year":"1959","journal-title":"J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115252_bib94","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2466\/pr0.1972.30.3.867","article-title":"Some Effects of scopolamine on acquisition and extinction performance in rats","volume":"30","author":"McCoy","year":"1972","journal-title":"Psychol. Rep."},{"issue":"4","key":"10.1016\/j.bbr.2024.115252_bib95","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3758\/BF03326592","article-title":"Scopolamine and food-reinforced behavior in the rat","volume":"4","author":"Plotnik","year":"1976","journal-title":"Physiol. Psychol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115252_bib96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(00)00403-9","article-title":"Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo","volume":"vol. 401","author":"Acquas","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-2999(97)89683-5","article-title":"Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A","volume":"327","author":"Gessa","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115252_bib98","first-page":"243","article-title":"The biodisposition and metabolism of anandamide in mice","volume":"282","author":"Willoughby","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643282400408X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643282400408X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:11:14Z","timestamp":1732248674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643282400408X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":98,"alternative-id":["S016643282400408X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2024.115252","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central cholinergic transmission modulates endocannabinoid-induced marble-burying behavior in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2024.115252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115252"}}